Status: Not yet recruiting
Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis
This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the clinical efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of multiple local injections of different doses of LP-005 injection in patients with moderate-to-severe periodontitis, and to investigate changes in biomarker levels.
Participants needed: 100
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Longbio Pharma (Suzhou) Co., Ltd.Updated: May 22, 2026Locations: 1
Eligibility criteria
Aged 18 to 70 years (inclusive), with no restriction on sex. [+3]
At the time of screening, the target tooth and/or adjacent teeth (as determined... [+24]